With formal integration initiatives, such as accountable care organizations, having modest effects, researchers analyzed the impact of informal clinical integration on cardiac surgery payments and found that patients who were treated in health systems with higher informal integration had greater savings.
Informal clinical integration among primary and specialty physicians is associated with lower spending in surgical care, according to a study published in JAMA Surgery.
With the varying costs of surgery across health systems, many have identified the fragmented nature of surgical care delivery as a culprit.
“Suboptimal coordination among clinicians around the time of the surgical episode can affect healthcare spending by increasing the likelihood that clinical care team members provide duplicate tests, treatments, or services,” wrote the authors of the study. “Fragmentation also impedes the ability of physicians to identify imminent postoperative needs of patients after hospital discharge, resulting in emergency department visits and readmissions to the hospital.”
To address this fragmentation, payers and providers nationwide have been teaming up and collaborating through initiatives such as accountable care organizations (ACOs) and the patient-centered medical home, which promotes and underscores the importance of clinical integration among physicians.
However, with modest results of organizations like these, the authors point to formal integration as a weakness and argue that informal integration may have greater positive impact. To study the effects, the authors analyzed surgical episode payments for 253,545 Medicare beneficiaries undergoing coronary artery bypass grafting procedures from January 1, 2008, through December 31, 2011.
Interactions were mapped between all physicians who treated the patients during their surgical episode, including primary care physicians and surgical and medical specialists. Interactions between physicians if they billed for the same beneficiary were documented, and multivariate regression models were fitted to evaluate the association between payments for each surgical episode made on a beneficiary’s behalf and the level of informal integration in the health system where the patient was treated.
The low level of informal clinical integration included 84,598 patients, the medium level included 84,442, and the high level included 84,505. Health systems with low and medium integration were more likely to have patients with comorbid illnesses and more patients from urban areas. They also had more physicians, more physicians who were geographically dispersed, and were less likely to use electronic health records, which suggests that health systems that treat more disadvantaged populations tend to be less informally integrated, according to the authors.
When patients were treated in health systems with higher informal integration, the greatest savings of lower estimated payments were from hospital readmissions (13%) and postacute care services (5.8%).
“These results support the idea that better informal integration of physicians during surgical care may improve patient coordination and lead to greater efficiency,” the authors wrote.
According to the authors, there are several implications from the study. First, the findings suggest that health system administrators and policy makers may benefit from viewing formal and informal clinical integration as 2 distinct phenomena. The findings also suggest that the possibility that informal integration may contribute to the success or failure of formal programs aimed at reducing fragmentation. Lastly, their index of informal integration may prove useful for health system administrators and researchers.
Reference
Funk RJ, Owen-Smith J, Kaufman SA, Nallamothu BK, Hollingsworth JM. Association of informal clinical integration of physicians with cardiac surgery payments [published online December 27, 2017]. JAMA Surg. doi: 10.1001/jamasurg.2017.5150. Accessed February 22, 2018.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More